Does DUPILUMAB Cause Skin hypertrophy? 149 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Skin hypertrophy have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
149
Reports of Skin hypertrophy with DUPILUMAB
0.0%
of all DUPILUMAB reports
2
Deaths
7
Hospitalizations
How Dangerous Is Skin hypertrophy From DUPILUMAB?
Of the 149 reports, 2 (1.3%) resulted in death, 7 (4.7%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Skin hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Skin hypertrophy?
SECUKINUMAB (134)
ADALIMUMAB (105)
ETANERCEPT (48)
METHOTREXATE (42)
RITUXIMAB (41)
TACROLIMUS (40)
OMALIZUMAB (35)
PREDNISOLONE (35)
SUNITINIB MALATE (32)
RIBOCICLIB (31)
Which DUPILUMAB Alternatives Have Lower Skin hypertrophy Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE